Jump to Main Content


Special Interest Sessions

back to top

ASH Choosing Wisely® Campaign: 2020 ASH Choosing Wisely Champions

Sunday, December 6, 2020, 12:00 p.m. - 12:45 p.m.

Please view the pre-recorded presentations prior to attending the corresponding Live Q&A session. Access to the on-demand content will be available starting on December 2 and will continue through the duration of your meeting subscription. CME is available for participation in the corresponding Live Q&A.

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.


Anita Rajasekhar , MD
University of Florida - Shands Hospital
Gainesville,  FL


Sriman Swarup , MD,MBBS
Texas Tech University Health Science Center
Lubbock,  TX
Choosing Wisely Champions

Hind Salama
King Abdulaziz Medical City
Riyadh,  Saudi Arabia
Choosing Wisely Champions

Arielle L Langer , MD,MPH
Brigham and Women's Hospital
Wellesley,  MA
Choosing Wisely Champions

back to top

ASH Practice Partnership Lunch Program

o CAM or Not To, That is the Question; Complementary and Alternative Medicine in Hematology

Access will be available starting on December 2 and will continue through the duration of your meeting subscription.

According to the National Cancer Institute, complementary and alternative medicine (CAM) is defined as medical products and practices that are not part of standard medical care. Alternative medicine, such as a specialized diet or other naturopathy, is used in lieu of standard medicine while complementary medicine, such as using acupuncture to help lessen some side effects of cancer treatment, is used along with standard medical treatments. While some CAM therapies, after careful evaluation, have been found to be safe and effective, research on others has been slow due to issues such as time, funding, and the ability to identify willing institutions and researchers. Additionally, some CAM therapies, such as medical marijuana, have run into regulatory hurdles, and there is little communication about CAM use among patients, CAM providers, and hematologists. Nevertheless, CAM is common among hematology patients, who, for example, use the analgesic properties of medical marijuana for cancer and sickle cell disease, but also for many who use these unconventional therapies to gain hope and improve quality of life.

This session will provide information about CAM therapies that may be discussed by patients with their hematologist. Additionally, the session will address the most common questions physicians hear from their patients about CAM therapies and how to conduct a constructive conversation between the physician and patient.


Chancellor E Donald , MD
Tulane University School of Medicine
New Orleans,  LA


Bipin N. Savani , MD
Vanderbilt University
Brentwood,  TN
Nutritional Supplements and Complementary/Alternative Medical Practices in Patients with Hematologic Diseases

Ilana Braun , MD
Dana-Farber Cancer Institute
Boston,  MA
The Role Medical Marijuana Plays in Cancer Care; A Focus on Clinical Trial Evidence

Shawn Seibert , MD
Illinois Cancercare
Peoria,  IL
Conversations and the Education of Physicians and Patients

back to top

Blood & Beyond

Medical Mistakes and Mracles: Surviving Hemophilia, HIV and Hepatitis C

Sunday, December 6, 2020, 2:00 p.m. - 3:30 p.m.


Nancy Berliner , MD
Editor-in-Chief, Blood, Brigham and Women's Hospital
Boston,  MA


Robert K. Massie , MA, PhD
activist, author, politician
Boston,  MA

back to top

How to Get Published in a Peer-Reviewed Journal

Access will be available starting on December 2 and will continue through the duration of your meeting subscription.

The ability to communicate one’s work effectively by publication in high-impact journals is a benchmark for success in academic medicine. Even high-quality work may not be accepted if not presented in a well-crafted manuscript. This panel will provide insight into the elements of a high-quality manuscript worthy of publication in Blood and tips on avoiding common errors that might result rejection.


Nancy Berliner , MD
Brigham and Women's Hospital
Boston,  MA

back to top

How to Peer Review a Scientific Paper

Access will be available starting on December 2 and will continue through the duration of your meeting subscription.

The Blood Advances Editor-in-Chief, Dr. Robert Negrin, will lead a panel discussion on How to Peer Review a Scientific Paper. The session will provide valuable information on the best practices of peer review from the editorial perspective for both basic and clinically relevant manuscripts. There are multiple professional benefits to becoming a reviewer. It allows the hematologist to stay current on research and developments in the field and can help in patient care, in the lab, and in the classroom. It also has the additional benefits of allowing the reviewer to be recognized by their colleagues, and the reviewer can use the experience to demonstrate professional development with their institution.


Robert S. Negrin , MD
Stanford University
Stanford,  CA


Margaret V. Ragni , MD,MPH
University of Pittsburgh
Pittsburgh,  PA

Constantine S. Tam , MBBS
Peter MacCallum Cancer Center, Royal Melbourne Hospital, and University of Melbourne
Melbourne,  VIC, Australia